Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,467 | 14,456 | 13,308 | 15,161 | 13,587 |
| Receivables | 95,913 | 104,933 | 113,508 | 108,082 | 105,337 |
| Inventories | 39,366 | 41,109 | 45,330 | 37,923 | 35,337 |
| Income taxes - deferred | 9,464 | 9,123 | 7,941 | 7,933 | 7,928 |
| TOTAL | $172,825 | $179,349 | $191,381 | $181,774 | $171,965 |
| Non-Current Assets | |||||
| PPE Net | 96,305 | 97,615 | 95,462 | 89,754 | 84,404 |
| Intangibles | 0 | 151,257 | 0 | 0 | 0 |
| Other Non-Current Assets | 146,572 | 11,279 | 155,505 | 150,368 | 151,020 |
| TOTAL | $242,877 | $260,151 | $250,967 | $240,122 | $235,424 |
| Total Assets | $415,702 | $439,500 | $442,348 | $421,896 | $407,389 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 455 | 506 | 669 | 658 | 667 |
| Accounts payable and accrued liabilities | 15,946 | 19,721 | 17,275 | 20,526 | 18,924 |
| Accrued Expenses | N/A | 9,825 | N/A | N/A | N/A |
| TOTAL | $30,291 | $40,007 | $45,093 | $46,985 | $45,849 |
| Non-Current Liabilities | |||||
| Long Term Debt | 94,000 | 95,121 | 97,688 | 84,052 | 78,965 |
| Deferred Revenues | N/A | 3,198 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 29,279 | 15,416 | 21,676 | 22,165 | 23,534 |
| TOTAL | $123,279 | $123,887 | $119,390 | $106,246 | $102,530 |
| Total Liabilities | $153,570 | $163,894 | $164,483 | $153,231 | $148,379 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,482 | 66,417 | 66,750 | 66,330 | 64,823 |
| Common Shares | 546 | 546 | 545 | 545 | 536 |
| Retained earnings | 74,629 | 88,309 | 90,634 | 81,578 | 74,516 |
| TOTAL | $262,132 | $275,606 | $277,865 | $268,665 | $259,010 |
| Total Liabilities And Equity | $415,702 | $439,500 | $442,348 | $421,896 | $407,389 |